Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dynamic Metabolic and Transcriptional Responses of Proteasome-Inhibited Neurons.
Suciu I, Delp J, Gutbier S, Ückert AK, Spreng AS, Eberhard P, Karreman C, Schreiber F, Madjar K, Rahnenführer J, Celardo I, Amelio I, Leist M. Suciu I, et al. Among authors: madjar k. Antioxidants (Basel). 2023 Jan 10;12(1):164. doi: 10.3390/antiox12010164. Antioxidants (Basel). 2023. PMID: 36671027 Free PMC article.
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.
Keller M, Rohlf K, Glotzbach A, Leonhardt G, Lüke S, Derksen K, Demirci Ö, Göçener D, AlWahsh M, Lambert J, Lindskog C, Schmidt M, Brenner W, Baumann M, Zent E, Zischinsky ML, Hellwig B, Madjar K, Rahnenführer J, Overbeck N, Reinders J, Cadenas C, Hengstler JG, Edlund K, Marchan R. Keller M, et al. Among authors: madjar k. J Exp Clin Cancer Res. 2023 Jan 20;42(1):25. doi: 10.1186/s13046-022-02578-w. J Exp Clin Cancer Res. 2023. PMID: 36670508 Free PMC article.
High Accuracy Classification of Developmental Toxicants by In Vitro Tests of Human Neuroepithelial and Cardiomyoblast Differentiation.
Seidel F, Cherianidou A, Kappenberg F, Marta M, Dreser N, Blum J, Waldmann T, Blüthgen N, Meisig J, Madjar K, Henry M, Rotshteyn T, Scholtz-Illigens A, Marchan R, Edlund K, Leist M, Rahnenführer J, Sachinidis A, Hengstler JG. Seidel F, et al. Among authors: madjar k. Cells. 2022 Oct 27;11(21):3404. doi: 10.3390/cells11213404. Cells. 2022. PMID: 36359802 Free PMC article.
Classification of Developmental Toxicants in a Human iPSC Transcriptomics-Based Test.
Cherianidou A, Seidel F, Kappenberg F, Dreser N, Blum J, Waldmann T, Blüthgen N, Meisig J, Madjar K, Henry M, Rotshteyn T, Marchan R, Edlund K, Leist M, Rahnenführer J, Sachinidis A, Hengstler JG. Cherianidou A, et al. Among authors: madjar k. Chem Res Toxicol. 2022 May 16;35(5):760-773. doi: 10.1021/acs.chemrestox.1c00392. Epub 2022 Apr 13. Chem Res Toxicol. 2022. PMID: 35416653 Free PMC article.
Correction to: Toxicogenomics directory of chemically exposed human hepatocytes.
Grinberg M, Stöber RM, Edlund K, Rempel E, Godoy P, Reif R, Widera A, Madjar K, Schmidt-Heck W, Marchan R, Sachinidis A, Spitkovsky D, Hescheler J, Carmo H, Arbo MD, van de Water B, Wink S, Vinken M, Rogiers V, Escher S, Hardy B, Mitic D, Apic G, Myatt G, Waldmann T, Mardinoglu A, Damm G, Seehofer D, Nüssler A, Weiss TS, Oberemm A, Lampen A, Schaap MM, Luijten M, van Steeg H, Thasler WE, Kleinjans JCS, Stierum RH, Leist M, Rahnenführer J, Hengstler JG. Grinberg M, et al. Among authors: madjar k. Arch Toxicol. 2022 Mar;96(3):945-946. doi: 10.1007/s00204-021-03206-w. Arch Toxicol. 2022. PMID: 35099568 No abstract available.
Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial.
Edlund K, Madjar K, Lebrecht A, Aktas B, Pilch H, Hoffmann G, Hofmann M, Kolberg HC, Boehm D, Battista M, Seehase M, Stewen K, Gebhard S, Cadenas C, Marchan R, Brenner W, Hasenburg A, Koelbl H, Solbach C, Gehrmann M, Tanner B, Weber KE, Loibl S, Sachinidis A, Rahnenführer J, Schmidt M, Hengstler JG. Edlund K, et al. Among authors: madjar k. Clin Cancer Res. 2021 Apr 15;27(8):2148-2158. doi: 10.1158/1078-0432.CCR-20-2662. Epub 2021 Feb 4. Clin Cancer Res. 2021. PMID: 33542080 Clinical Trial.
22 results